IN-VITRO INTERACTIONS BETWEEN ANTITUMOUR ANTIBODIES AND ANTI-ANTIBODIES IN MALIGNANCY
- 21 December 1974
- journal article
- Published by Elsevier in The Lancet
- Vol. 304 (7895), 1481-1483
- https://doi.org/10.1016/s0140-6736(74)90219-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- PRESENCE AND POSSIBLE ROLE OF ANTI-IgG ANTIBODIES IN HUMAN MALIGNANCYThe Lancet, 1974
- Cell-Mediated Immunity and Specific Serum Factors in Human Cancer: The Leukocyte Adherence Inhibition Test2JNCI Journal of the National Cancer Institute, 1974
- Detection of Anti-tumour Cell Mediated Immunity and Serum Blocking Factors in Cancer Patients by the Leucocyte Adherence Inhibition TestBritish Journal of Cancer, 1974
- Leukocyte adherence inhibition: A simple test for cell‐mediated tumour immunity and serum blocking factorsInternational Journal of Cancer, 1972
- Elution of “blocking factors” from human tumors, capable of abrogating tumor‐cell destruction by specifically immune lymphocytesInternational Journal of Cancer, 1972
- “Unblocking” Serum Activity in vitro in the Polyoma System may Correlate with Antitumour Effects of Antiserum in vivoNature New Biology, 1971
- Possible Explanation for Loss of Detectable Antibody in Patients with Disseminated Malignant MelanomaNature, 1971
- Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasmsInternational Journal of Cancer, 1971
- Tumour-specific Antibodies in Human Malignant Melanoma and their Relationship to the Extent of the DiseaseBMJ, 1969
- Glutaraldehyde, cyanuric choloride and tetraazotiexe O-dianisidine as coupling reagents in the passive hemagglutination testImmunochemistry, 1969